Using population data to improve lupus care
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health
This project follows a diverse group of people with lupus over time to find causes of pain, fatigue, and early kidney damage so care can be improved for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11129592 on NIH RePORTER |
What this research studies
If you join, you'll be part of a long-term group of people with lupus who are followed regularly by NYU clinicians and researchers. The team will collect medical records, surveys about symptoms like pain and fatigue, and new biological samples to look for biological reasons behind those symptoms. They will study how disease severity and additional health problems change over time and whether race, age, or socioeconomic factors affect outcomes. The project also tests a new way to find early kidney problems in people at high risk so treatment can start sooner.
Who could benefit from this research
Good fit: Ideal candidates are people diagnosed with systemic lupus erythematosus (SLE), especially those from racial or ethnic minority groups or those with concerns about kidney involvement.
Not a fit: People without lupus, or those unwilling to share medical records or provide biospecimens, are unlikely to receive direct benefit from participation.
Why it matters
Potential benefit: If successful, this work could help detect kidney disease earlier and lead to better-targeted treatments that reduce pain, fatigue, and long-term complications for people with lupus.
How similar studies have performed: Large lupus cohort studies have already identified important risk factors and health disparities, but using new biospecimens to pinpoint causes of pain/fatigue and a novel early-kidney-detection approach is relatively new.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Izmirly, Peter — New York University School of Medicine
- Study coordinator: Izmirly, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.